Abstract: A system 10 comprises first and second user machines 12, 14. Information content can be communicated from the first machine 12 to the second machine 14. The first machine 12 is in a first network 16. The second machine 14 is in a second network 18. Security in the second network 18 cannot be controlled from the first machine 12. The machine 12 sends information content 24 to a server 22 which stores the content 24. Content 24 is sent to the server 22 as a datastream with control content 26. The server 22 prevents access to the content 24 from the second machine 14, except by a second user authorised by the control content 26.

Abstract: We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.

Abstract: We disclose a method of diagnosis of a disease, or susceptibility to a disease associated with abnormal cell-cell adhesion between epithelial cells, the method comprising detection of a mutation in a nucleic acid encoding an adhesion protein, a protease, or a protease inhibitor of an individual. Methods of making medicaments and methods of treatment and/or prophylaxis are also disclosed.

Abstract: A composite armor panel and method of manufacturing the same are disclosed. In one embodiment, a plurality of ceramic spheres are positioned in contact with an armor substrate. A polyurea layer is interposed between the plurality of ceramic spheres such that the polyurea layer partially encapsulates the plurality of ceramic spheres and bonds the plurality of ceramic spheres to the armor substrate. The plurality of ceramic spheres are partially exposed and oriented in a direction of anticipated impact.

Abstract: An isocyanate-reactive component is disclosed that reacts with a liquid polyisocyanate or polyisocyanate prepolymer in the preparation of a polyurethane-polyurea polymer. In one embodiment, a polyisocyanate component is reacted with an isocyanate-reactive component. The polyisocyanate component has an NCO group content of about 3% to about 50% and an average functionality of about 2 to about 3. The isocyanate-reactive component includes from about 20% to about 90% by weight, based on 100% by weight of the isocyanate-reactive component, of at least one organic compound having a mercaptan functional moiety.

Abstract: A polyisocyanate prepolymer component is disclosed that reacts with an isocyanate-reactive component in the preparation of a polyurethane-polyurea polymer. In one embodiment, a polyisocyanate in an amount of from about 50% to about 98% is reacted with a reactive component in an amount from about 2% to about 50% by weight. The polyisocyanate has an average functionality of about 2 to about 3. The reactive component includes from about 20% to about 100% by weight, based on 100% by weight of the reactive component, of at least one organic compound having a mercaptan functional moiety. The resulting polyisocyanate prepolymer component has an NCO group content of about 3% to about 50%.

Abstract: A system and method are disclosed that provide for coating a substrate. In one embodiment, the coating system includes a polyurethane-polyurea polymer disposed on a surface of the substrate. The polyurethane-polyurea polymer has a mercaptan content of about 0.5% to about 5.0% and is the reaction product of a polyisocyanate prepolymer component and an isocyanate-reactive component.

Abstract: Tubular structures and methods for making tubular structures are disclosed. In one embodiment, the method for making a tubular structure includes modifying a surface of a structure. After modifying the surface, the structure is bonded to a metal layer, thereby forming a composite sheet. Then, the composite sheet is shaped into a tubular structure.

Abstract: The inventive concept relates to the inactivation of allergens using inhibitors for hydrolytic enzymes, and preferably proteases. Embraced within the overall inventive concept is the use of hydrolytic enzyme inhibitors for manufacture of medicaments for the prophylactic treatment of allergic conditions, and formulations for their use. Also, there is included a method for the manufacture of air treatment devices with the enzyme inhibitor bound to the surface of the support material such as an air filter. There is also a formulation containing the enzyme inhibitors for inactivating allergenic residues on fabrics or carpets.

Abstract: We disclose a method of diagnosis of a disease, or susceptibility to a disease associated with abnormal cell-cell adhesion between epithelial cells, the method comprising detection of a mutation in a nucleic acid encoding an adhesion protein, a protease, or a protease inhibitor of an individual.

Abstract: Tubular structures and methods for making tubular structures are disclosed. In one embodiment, the method for making a tubular structure includes modifying a surface of a structure. After modifying the surface, the structure is bonded to a metal layer, thereby forming a composite sheet. Then, the composite sheet is shaped into a tubular structure.

Abstract: We describe methods and compositions for treating a patient suffering from a hyperproliferative disorder or photoageing. Our methods involve blocking the activity of a retinol binding protein receptor (RBPr) in cells of the patient, and/or administering to the patient an antagonist of a retinol binding protein receptor (RBPr) and/or lowering the endogenous level of retinoic acid (RA) in cells of said patient.